Aprea Therapeutics Inc.

(APRE) Trade

Symbol has changed to a new ticker symbol

(APRED)

By |

Profile

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Contact Information

Website: www.aprea.com
Email: chris.schade@aprea.com
Main Phone: +1 617 463-9385
Address: 535 Boylston Street
Address 2: Suite 170
State: MA
City / Town: Boston
Country: US
Postal Code: 02116

Issuer Information

Exchange: NGS
CEO: Christian S. Schade
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Contact Information

Website: www.aprea.com
Email: chris.schade@aprea.com
Main Phone: +1 617 463-9385
Address: 535 Boylston Street
Address 2: Suite 170
State: MA
City / Town: Boston
Country: US
Postal Code: 02116

Issuer Information

Exchange: NGS
CEO: Christian S. Schade
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 25.24 $ -1.21 (-4.57%)
Last Price 25.24 Change $ -1.21 Change % -4.57 Tick N/A
Bid 24.88 Bid Size 100.00 Ask 35.00 Ask Size 300.00
Open 27.57 High 28.00 Low 24.66 Prev Close 26.45
Last Trade Volume 199,544 52 Wk Hi 53.12 52 Wk Low 19.67
Market Cap 534.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,186,827.00 EPS (TTM) -5.70 PE Ratio -4.60 Exchange NGS